Title : Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.

Pub. Date : 2015 May

PMID : 25712859






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Canavan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous system (CNS) NAA and progressively worsening leukodystrophy. N-acetylaspartate aspartoacylase Mus musculus
2 Canavan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous system (CNS) NAA and progressively worsening leukodystrophy. N-acetylaspartate aspartoacylase Mus musculus
3 Canavan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous system (CNS) NAA and progressively worsening leukodystrophy. N-acetylaspartate aspartoacylase Mus musculus